Clinical trial
YN001 liposomal rosuvastatin (Beijing Inno Medicine)
NCT06048588
Активно-таргетируемый липосомальный розувастатин; общая регистрация N=144, завершён. Предварительный анализ на ESC 2025 по 16 завершившим пациентам.
No news refers to this card yet.
Also in the catalogue
- YN001 + evolocumab (Australia)Clinical trial
- PURIFY-TIMI 81 (YN001)Clinical trial
- UDP-003 (Cyclarity), 7-ketocholesterol clearanceClinical trial
- CTX310 Phase 1b (secondary identifier NCT07491172)Clinical trial
- VERVE-102 Heart-2Clinical trial
- Long-term follow-up of gene-editing recipients (up to 15 years)Clinical trial
Scales
Identifiers
- NCT
- NCT06048588
Original sources
Details
- Status
- Completed
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.